ESE audit on management of Adult Growth Hormone Deficiency in clinical practice.

CONCLUSION: Despite guideline recommendations, GH replacement in AGHD is still not available or reimbursed in all European countries. Knowledge among professionals and health administrators needs improvement to optimize care of adults with GHD.
PMID: 33320830 [PubMed - as supplied by publisher]

Source: European Journal of Endocrinology - December 1, 2020 Category: Endocrinology Authors: Martel-Duguech LM, Jorgensen JOL, Korbonits M, Johannsson G, Webb SM, Amadidou F, Mintziori G, Arosio M, Giavoli C, Badiu C, Boschetti M, Ferone D, Ricci Bitti S, Brue T, Albarel F, Cannavò S, Cotta OR, Carvalho D, Salazar D, Christ E, Debono M, Dusek T, Tags: Eur J Endocrinol Source Type: research